cromakalim has been researched along with Ventricular Fibrillation in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (61.54) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Archondo, T; Chin, A; García-Torrent, MJ; González, P; Macaya, C; Molina-Morúa, R; Moreno, J; Pérez-Castellano, N; Pérez-Villacastín, J; Quintanilla, JG; Rodríguez-Bobada, C; Usandizaga, E | 1 |
| Gao, JY; Ito, K; Ito, Y; Shimokawa, H; Shiroto, T; Tsuburaya, R; Yasuda, S | 1 |
| Csonka, C; Csont, T; Ferdinandy, P; Onody, A | 1 |
| D'Alonzo, AJ; Darbenzio, RB; Hess, TA; Sewter, JC | 1 |
| Curtis, MJ; Hearse, DJ; Rees, SA; Tsuchihashi, K | 1 |
| Hellegouarch, A; Tosaki, A | 1 |
| Droy-Lefaix, MT; Ferdinandy, P; Koltai, M; Szilvássy, Z; Tarrade, T | 1 |
| Aya, G; de La Coussaye, JE; Delye, B; Eledjam, JJ; Juan, JM; Péray, P; Robert, E; Sassine, A | 1 |
| Baczkó, I; Leprán, I; Papp, JG | 1 |
| Cobbe, SM; Hicks, MN; Kane, KA; Wolk, R | 1 |
| Athill, CA; Blanche, C; Chen, PS; Czer, L; Doshi, R; Fishbein, MC; Garfinkel, A; Karagueuzian, HS; Kass, RM; Kim, YH; Ong, JJ; Trento, A; Weiss, JN; Wu, TJ; Yashima, M | 1 |
| Chen, PS; Garfinkel, A; Karagueuzian, HS; Kil, JR; Kim, YH; Lee, MH; Qu, Z; Voroshilovsky, O; Weiss, JN | 1 |
| Chang, MJ; Chen, YC; Cheng, CY; Lee, YM; Peng, YY; Sheu, JR; Yen, MH | 1 |
13 other study(ies) available for cromakalim and Ventricular Fibrillation
| Article | Year |
|---|---|
KATP channel opening accelerates and stabilizes rotors in a swine heart model of ventricular fibrillation.
Topics: Animals; Cromakalim; Disease Models, Animal; Electrophysiological Phenomena; Humans; In Vitro Techniques; KATP Channels; Models, Cardiovascular; Sus scrofa; Ventricular Fibrillation; Voltage-Sensitive Dye Imaging | 2013 |
Eicosapentaenoic acid reduces ischemic ventricular fibrillation via altering monophasic action potential in pigs.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Cromakalim; Disease Models, Animal; Eicosapentaenoic Acid; Fatty Acids; Gene Expression Regulation; Male; Myocardial Ischemia; Parasympatholytics; Potassium Channels, Inwardly Rectifying; Swine; Ventricular Fibrillation | 2011 |
Defibrillatory action of glibenclamide is independent from ATP-sensitive K+ channels and free radicals.
Topics: Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Chromatography, High Pressure Liquid; Coronary Circulation; Cromakalim; Electric Stimulation; Glyburide; Heart Rate; Hydroxyl Radical; In Vitro Techniques; Male; Potassium Channel Blockers; Potassium Channels; Rats; Rats, Wistar; Superoxides; Vasodilator Agents; Ventricular Fibrillation | 2003 |
Effects of cromakalim or glibenclamide on arrhythmias and dispersion of refractoriness in chronically infarcted in anesthetized dogs.
Topics: Adenosine Triphosphate; Anesthesia; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzopyrans; Blood Pressure; Cromakalim; Dogs; Electric Stimulation; Electrophysiology; Female; Glyburide; Heart Rate; In Vitro Techniques; Male; Myocardial Infarction; Potassium Channels; Pyrroles; Refractory Period, Electrophysiological; Ventricular Fibrillation; Ventricular Function | 1995 |
Combined administration of an IK(ATP) activator and Ito blocker increases coronary flow independently of effects on heart rate, QT interval, and ischaemia-induced ventricular fibrillation in rats.
Topics: Animals; Anti-Arrhythmia Agents; Benzopyrans; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Coronary Circulation; Cromakalim; Cyclopropanes; Drug Synergism; Drug Therapy, Combination; Electrocardiography; Heart Rate; Hemodynamics; In Vitro Techniques; Injections, Intravenous; Male; Myocardial Ischemia; Potassium Channels; Pyrroles; Rats; Rats, Wistar; Vasodilator Agents; Ventricular Fibrillation | 1993 |
Adenosine triphosphate-sensitive potassium channel blocking agent ameliorates, but the opening agent aggravates, ischemia/reperfusion-induced injury. Heart function studies in nonfibrillating isolated hearts.
Topics: Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Benzopyrans; Cromakalim; Dose-Response Relationship, Drug; Glyburide; Guinea Pigs; Magnetic Resonance Spectroscopy; Male; Myocardial Reperfusion Injury; Myocardium; Potassium Channels; Pyrroles; Tachycardia, Ventricular; Ventricular Fibrillation | 1994 |
KATP channel modulation in working rat hearts with coronary occlusion: effects of cromakalim, cicletanine, and glibenclamide.
Topics: Animals; Anti-Arrhythmia Agents; Benzopyrans; Coronary Circulation; Coronary Disease; Cromakalim; Glyburide; Heart; Ion Channel Gating; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Potassium Channels; Pyridines; Pyrroles; Rats; Rats, Wistar; Ventricular Fibrillation | 1995 |
Comparison of proarrhythmogenic effects of two potassium channel openers, levcromakalim (BRL 38227) and nicorandil (RP 46417): a high-resolution mapping study on rabbit heart.
Topics: Animals; Arrhythmias, Cardiac; Benzopyrans; Bradycardia; Cromakalim; Dose-Response Relationship, Drug; Electrophysiology; Heart; In Vitro Techniques; Isosorbide Dinitrate; Niacinamide; Nicorandil; Potassium Channels; Pyrroles; Rabbits; Tachycardia; Vasodilator Agents; Ventricular Fibrillation | 1997 |
KATP channel modulators increase survival rate during coronary occlusion-reperfusion in anaesthetized rats.
Topics: Action Potentials; Adenosine Triphosphate; Analysis of Variance; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzopyrans; Blood Pressure; Calcium Channel Blockers; Coronary Disease; Cromakalim; Disease Models, Animal; Dose-Response Relationship, Drug; Electrocardiography; Glyburide; Guanidines; Heart Rate; Male; Myocardial Reperfusion Injury; Pinacidil; Potassium Channels; Pyrroles; Rats; Rats, Sprague-Dawley; Survival Rate; Vasodilator Agents; Ventricular Fibrillation | 1997 |
Relevance of inter- and intraventricular electrical dispersion to arrhythmogenesis in normal and ischaemic rabbit myocardium: a study with cromakalim, 5-hydroxydecanoate and glibenclamide.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Cromakalim; Decanoic Acids; Glyburide; Heart; Hydroxy Acids; In Vitro Techniques; Male; Myocardial Ischemia; Potassium Channels; Rabbits; Refractory Period, Electrophysiological; Ventricular Fibrillation | 1999 |
Relation between cellular repolarization characteristics and critical mass for human ventricular fibrillation.
Topics: Action Potentials; Aged; Cromakalim; Electric Stimulation; Female; Heart Transplantation; Heart Ventricles; Humans; Male; Middle Aged; Organ Size; Patch-Clamp Techniques; Perfusion; Potassium Channels; Stimulation, Chemical; Tissue Donors; Ventricular Fibrillation | 1999 |
Preventing ventricular fibrillation by flattening cardiac restitution.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Bretylium Compounds; Cardiac Pacing, Artificial; Computer Simulation; Cromakalim; Diastole; Drug Design; Drug Evaluation, Preclinical; Fluorescent Dyes; Heart Conduction System; Models, Biological; Pyridinium Compounds; Swine; Ventricular Fibrillation | 2000 |
The antihypertensive and cardioprotective effects of (-)-MJ-451, an ATP-sensitive K(+) channel opener.
Topics: Adenosine Triphosphate; Animals; Antihypertensive Agents; Aorta, Thoracic; Arrhythmias, Cardiac; Benzopyrans; Blood Pressure; Cromakalim; Dose-Response Relationship, Drug; Heart; Heart Rate; Hemodynamics; In Vitro Techniques; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Potassium Channels; Pyrrolidinones; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Rats, Wistar; Vasodilation; Vasodilator Agents; Ventricular Fibrillation | 2000 |